Structure and function of cellular deoxyribonucleoside kinases

Cellular and Molecular Life Sciences

Volumn 59, Issue 8, 2002, Pages 1327-1346

  Eriksson, S ^a   Munch Petersen, B ^b   Johansson, K ^a,c   Ecklund, H ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b ROSKILDE UNIVERSITY   (Denmark)

^c Centre National de la Recherche Scientifique   (France)

Author keywords

Biochemical properties; Deoxyribonuncleoside kinases; Feedback inhibition; Nucleoside analogs; Phosphoryl transfer; Substrate specificity

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CLADRIBINE; COMPLEMENTARY DNA; CYTARABINE; CYTOSTATIC AGENT; DEOXYRIBONUCLEOSIDE; DEOXYRIBONUCLEOSIDE KINASE; FLUDARABINE; GEMCITABINE; LAMIVUDINE; MESSENGER RNA; NUCLEOSIDE ANALOG; STAVUDINE; THYMIDINE KINASE; THYMIDINE KINASE INHIBITOR; THYMINE ARABINOSIDE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

BIOSYNTHESIS; CATALYSIS; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN; NEGATIVE FEEDBACK; NONHUMAN; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN CONFORMATION;

MAMMALIA;

EID: 0036693511     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8511-x     Document Type: Review

References (122)

1. Reduction of ribonucleotides
2. Mammalian deoxyribonucleoside kinases
3. Nucleoside transporters of mammalian cells
4. Functional expression of a multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster and its C-terminal deletion mutants
5. Four deoxynucleoside kinase activities from Drosophila melanogaster are contained within a single monomeric enzyme, a new multifunctional deoxynucleoside kinase
6. Structure to 1.9 Å resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X-ray crystallographic comparison with binding of aciclovir
7. Crystal structures of the thymidine kinase from herpes simplex virus type-1 in complex with deoxythymidine and ganciclovir
8. Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands
9. The three-dimensional structure of thymidine kinase from herpes simplex virus type 1
10. The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue
11. Structural basis for substrate specificities of cellular deoxyribonucleoside kinases
12. Mitochondrial diseases in man and mouse
13. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA
14. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy
15. Induction of an apoptotic program in cell-free extracts by 2-chloro-2′-deoxyadenosine 5′-triphosphate and cytochrome c
16. Effective treatment of experimental glioblastoma by HSV vector-mediated TNFalpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration
17. Gene therapy for endometrial carcinoma with the herpes simplex thymidine kinase gene
18. Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase
19. Identification of residues involved in the specificity and regulation of the highly efficient multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster
20. Human deoxythymidine kinase II: Substrate specificity and kinetic behavior of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia
21. Differences in the kinetic properties of thymidine kinase isoenzymes in unstimulated and phytohemagglutinin-stimulated human lymphocytes
22. Human cytosolic thymidine kinase. Purification and physical characterization of the enzyme from HeLa cells
23. Co-purification of thymidylate kinase and cytosolic thymidine kinase from human term placenta by affinity chromatography
24. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides
25. Human thymidine kinase 1. Regulation in normal and malignant cells
26. Assignment of the gene for galactokinase to human chromosome 17 and its regional localisation to band q21-22
27. FISH localization of the soluble thymidine kinase gene (TK1) to human 17q25, a region of chromosomal loss in sporadic breast tumors
28. An integrated physical and gene map of human distal chromosome 17q24-proximal 17q25 encompassing multiple disease loci
29. Regulation of thymidine kinase synthesis in human cells
30. Induction of thymidine kinases in phytohaemagglutinin-stimulated human lymphocytes
31. Regulation of human thymidine kinase during the cell cycle
32. Genetic analysis of the human thymidine kinase gene promoter
33. Control of thymidine kinase mRNA during the cell cycle
34. Cell-cycle-specific interaction of nuclear DNA-binding proteins with a CCAAT sequence from the human thymidine kinase gene
35. Role of the promoter in the regulation of the thymidine kinase gene
36. A 50-base-pair g1/s-regulated region in the promoter of the human thymidine kinase gene and its binding to factors
37. Regulation of thymidine kinase during growth, cell cycle and differentiation
38. Cyclin D1/cdk2 kinase is present in a G1 phase-specific protein complex Yi1 that binds to the mouse thymidine kinase gene promoter
39. Transcription factors of the Sp1 family: Interaction with E2F and regulation of the murine thymidine kinase promoter
40. Overexpression of human thymidine kinase mRNA without corresponding enzymatic activity in patients with chronic lymphatic leukemia
41. Different regulation of the human thymidine kinase promoter in normal human diploid IMR-90 fibroblasts and HeLa cells
42. The regulation of thymidine kinase in HL-60 human promyeloleukemia cells
43. Differential phosphorylation of human thymidine kinase in proliferating and M phase-arrested human cells
44. Serine 13 is the site of mitotic phosphorylation of human thymidine kinase
45. Interaction of human thymidine kinase 1 with p21(Waf1)
46. Mutations in the thymidine kinase gene that allow expression of the enzyme in quiescent (G0) cells
47. Cell cycle regulation of thymidine kinase: Residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis
48. Carboxy-terminal residues of mouse thymidine kinase are essential for rapid degradation in quiescent cells
49. Mouse thymidine kinase stability in vivo and after in vitro translation
50. Identification of the ATP-binding domain of vaccinia virus thymidine kinase
51. Reversible ATP-dependent transition between two forms of human cytosolic thymidine kinase with different enzymatic properties
52. Expression and substrate specificities of human thymidine kinase 1, thymidine kinase 2 and deoxycytidine kinase
53. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase
54. Expression of human mitochondrial thymidine kinase in Escherichia coli: Correlation between the enzymatic activity of pyrimidine nucleoside analogues and their inhibitory effect on bacterial growth
55. Different affinity of the two forms of human cytosolic thymidine kinase towards pyrimidine analogs
56. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs
57. Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases
58. Synthesis of 5-(carboranylalkylmercapto)-2′-deoxyuridines and 3-(carboranylalkyl) thymidines and their evaluation as substrates for human thymidine kinases 1 and 2
59. Ligands for the affinity chromatography of mammalian thymidine kinase. 1: Strategy, synthesis and evaluation
60. Cloning and expression of human deoxycytidine kinase cDNA
61. Deoxycytidine kinase from human leukemic spleen: Preparation and characteristics of homogeneous enzyme
62. Deoxycytidine kinase. 3. Kinetics and allosteric regulation of the calf thymus enzyme
63. Genomic structure and chromosomal localization of the human deoxycytidine kinase gene
64. Cloning and expression of mouse deoxycytidine kinase. Pure recombinant mouse and human enzymes show differences in substrate specificity
65. Cell cycle regulation of deoxycytidine kinase. Evidence for post-transcriptional control
66. Human deoxycytidine kinase is located in the cell nucleus
67. The intracellular localization of deoxycytidine kinase
68. Kinetic analysis of human deoxycytidine kinase with the true phosphate donor uridine triphosphate
69. Binding of substrates to human deoxycytidine kinase studied with ligand-dependent quenching of enzyme intrinsic fluorescence
70. A pre-steady-state kinetic analysis of substrate binding to human recombinant deoxycytidine kinase: A model for nucleoside kinase action
71. Multisubstrate analogs for deoxynucleoside kinases. Triphosphate end products and synthetic bisubstrate analogs exhibit identical modes of binding and are useful probes for distinguishing kinetic mechanisms
72. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo
73. Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine
74. Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin
75. Nucleotide specificity of human deoxycytidine kinase
76. Nucleoside triphosphate donors for nucleoside kinases: Donor properties of UTP with human deoxycytidine kinase
77. Stereoisomeric selectivity of human deoxyribonucleoside kinases
78. Lack of enantiospecificity of human 2′-deoxycytidine kinase: Relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agents
79. Low enantioselectivities of human deoxycytidine kinase and human deoxyguanosine kinase with respect to 2′-deoxyadenosine, 2′-deoxyguanosine and their analogs
80. Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2′-deoxycytidine kinase
81. Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration
82. Unique metabolism of a novel antiviral L-nucleoside analog, 2′-fluoro-5-methyl-beta-L-arabinofuranosyluracil: A substrate for both thymidine kinase and deoxycytidine kinase
83. 2H double-labelled 2′-deoxynucleosides and deoxycytidine kinase (dCK)
84. Pharmacology of purine nucleoside analogues
85. Activation of deoxycytidine kinase during inhibition of DNA synthesis by 2-chloro-2′-deoxyadenosine (Cladribine) in human lymphocytes
86. Collateral sensitivity to gemcitabine (2′,2′-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines
87. Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2
88. Human thymidine kinase 2: Molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucloeoside substrates
89. Cloning and characterization of full-length mouse thymidine kinase 2: The N-terminal sequence directs import of the precursor protein into mitochondria
90. Cloning and expression of human mitochondrial deoxyguanosine kinase cDNA
91. 2′-O-Acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase
92. The enantioselectivity of enzymes involved in current antiviral therapy using nucleoside analogues: A new strategy?
93. Antiviral guanosine analogs as substrates for deoxyguanosine kinase: Implications for chemotherapy
94. Translocation (2;14)(p13;q32) in CD10+; CD13+ acute lymphatic leukemia
95. Substrate specificity of mitochondrial 2′-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine
96. Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs
97. The enantioselectivity of the cellular deoxynucleoside kinases
98. Cloning and expression of human deoxyguanosine kinase cDNA
99. Mitochondrial and submitochondrial localization of human deoxyguanosine kinase
100. Apoptosis induces efflux of the mitochondrial matrix enzyme deoxyguanosine kinase
101. The single deoxynucleoside kinase in Drosophila melanogaster, Dm-dNK, is multifunctional and differs from the mammalian deoxynucleoside kinases
102. Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster
103. The genome sequence of Drosophila melanogaster
104. Deoxyribonucleoside kinases belonging to the thymidine kinase 2 (TK2)-like group vary significantly in substrate specificity, kinetics and feed-back regulation
105. The multifunctional deoxynucleoside kinase of insect cells is a target for the development of new insecticides
106. Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol
107. Bystander effects of cancer cell lines transduced with the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster and synergistic enhancement by hydroxyurea
108. A phase 1-2 clinical trial of gene therapy for recurrent gliobtastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
109. High-resolution structures of adenylate kinase from yeast ligated with inhibitor Ap5A, showing the pathway of phosphoryl transfer
110. Kinetic mechanism and end-product regulation of deoxyguanosine kinase from beef liver mitochondria
111. Human deoxycytidine kinase: Kinetic mechanism and end product regulation
112. Site-directed mutagenesis of a conserved domain in vaccinia virus thymidine kinase. Evidence for a potential role in magnesium binding
113. A single amino acid substitution abolishes feedback inhibition of vaccinia virus thymidine kinase
114. Valine, not methionine, is amino acid 106 in human cytosolic thymidine kinase (TK1). Impact on oligomerization, stability, and kinetic properties
115. Human thymidine kinase gene: Molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells
116. Sequence, structure and promoter characterization of the human thymidine kinase gene
117. Evaluation of the secondary structure of vaccinia-virus thymidine kinase by circular-dichroism spectroscopy of overlapping synthetic peptides
118. Nucleoside binding site of herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography
119. Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine
120. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures